PGC-1 alpha regulates HO-1 expression, mitochondrial dynamics and biogenesis: Role of epoxyeicosatrienoic acid

Prostaglandins and Other Lipid Mediators

Volumn 125, Issue , 2016, Pages 8-18

  Singh, Shailendra P ^a   Schragenheim, Joseph ^a   Cao, Jian ^b   Falck, John R ^c   Abraham, Nader G ^a,d   Bellner, Lars ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epoxyeicosatrienoic acid; HO 1; Metabolic dysfunction

Indexed keywords

ADIPONECTIN; CARBON DIOXIDE; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE SUBUNIT IV; EPOXYICOSATRIENOIC ACID; HEME OXYGENASE 1; HYDROLASE; MANGANESE SUPEROXIDE DISMUTASE; MESODERM SPECIFIC TRANSCRIPT; MITOCHONDRIAL PROTEIN; MITOFUSIN 1; MITOFUSIN 2; OPTIC ATROPHY 1 PROTEIN; PATERNALLY EXPRESSED GENE 1 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PR DOMAIN CONTAINING 16; SIRTUIN 3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1; ZINC FINGER PROTEIN; 2-(11-(NONYLOXY)UNDEC-8-ENAMIDO)SUCCINIC ACID; ASPARTIC ACID; DIHOMO GAMMA LINOLENIC ACID; DNA BINDING PROTEIN; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN; MESODERM SPECIFIC TRANSCRIPT PROTEIN; PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA COACTIVATOR-1; PRDM16 PROTEIN, MOUSE; PROTEIN; SIRT3 PROTEIN, MOUSE; SUPEROXIDE DISMUTASE;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; INTRAPERITONEAL FAT; LENTIVIRINAE; LIPID DIET; LIPID STORAGE; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL DYNAMICS; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; PROTEIN INDUCTION; SUBCUTANEOUS FAT; THERMOGENESIS; 3T3-L1 CELL LINE; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; METABOLISM; ORGANELLE BIOGENESIS;

3T3-L1 CELLS; 8,11,14-EICOSATRIENOIC ACID; ADIPOCYTES; ADIPONECTIN; ANIMALS; ASPARTIC ACID; CELL DIFFERENTIATION; DIET, HIGH-FAT; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE KNOCKDOWN TECHNIQUES; HEME OXYGENASE-1; HOMEOSTASIS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MITOCHONDRIAL DYNAMICS; ORGANELLE BIOGENESIS; OXYGEN CONSUMPTION; PROTEINS; SIRTUIN 3; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS; UNCOUPLING PROTEIN 1;

EID: 84979734788     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2016.07.004     Document Type: Article

References (80)

1. [1] Peterson, S.J., Vanella, L., Gotlinger, K., Jiang, H., Bialczak, A., Singh, S.P., et al. Oxidized HDL is a potent inducer of adipogenesis and causes activation of the ang-II and 20-HETE systems in human obese females. Prostaglandins Other Lipid Mediat., 2016 PMID: 27179555.
2. [2] Hall, J.E., The kidney, hypertension, and obesity. Hypertension 41/3:Pt 2 (2003), 625–633.
3. [3] Brook, R.D., Bard, R.L., Rubenfire, M., Ridker, P.M., Rajagopalan, S., Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults. Am. J. Cardiol. 88/11 (2001), 1264–1269.
4. [4] Vigili de, K.S., Kiwanuka, E., Tiengo, A., Avogaro, A., Visceral obesity is characterized by impaired nitric oxide-independent vasodilation. Eur. Heart J. 24/13 (2003), 1210–1215.
5. [5] Zeldin, D.C., Epoxygenase pathways of arachidonic acid metabolism. J. Biol. Chem. 276/39 (2001), 36059–36062.
6. [6] Capdevila, J.H., Falck, J.R., Harris, R.C., Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase. J. Lipid Res. 2 (2000), 163–181.
7. [7] Node, K., Huo, Y., Ruan, X., Yang, B., Spiecker, M., Ley, K., et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285/5431 (1999), 1276–1279.
8. [8] Spiecker, M., Liao, J.K., Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids. Arch. Biochem. Biophys. 433/2 (2005), 413–420.
9. [9] Abraham, N.G., Sodhi, K., Silvis, A.M., Vanella, L., Favero, G., Rezzani, R., et al. CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype. Hypertension 64/6 (2014), 1352–1361.
10. [10] Imig, J.D., Eicosanoids and renal damage in cardiometabolic syndrome. Expert Opin. Drug Metab. Toxicol. 4/2 (2008), 165–174.
11. [11] Kim, D.H., Vanella, L., Inoue, K., Burgess, A., Gotlinger, K., Manthati, V.L., et al. Epoxyeicosatrienoic acid agonist regulates human mesenchymal stem cell-derived adipocytes through activation of HO-1-pAKT signaling and a decrease in PPARgamma. Stem Cells Dev. 19/12 (2010), 1863–1873.
12. [12] Sodhi, K., Puri, N., Inoue, K., Falck, J.R., Schwartzman, M.L., Abraham, N.G., EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels. Prostaglandins Other Lipid Mediat. 98/3–4 (2012), 133–142.
13. [13] Zha, W., Edin, M.L., Vendrov, K.C., Schuck, R.N., Lih, F.B., Jat, J.L., et al. Functional characterization of cytochrome P450-derived epoxyeicosatrienoic acids in adipogenesis and obesity. J. Lipid Res. 55/10 (2014), 2124–2136.
14. [14] Abraham, N.G., Kappas, A., Heme oxygenase and the cardiovascular-renal system. Free Radic. Biol. Med. 39/1 (2005), 1–25.
15. [15] Abraham, N.G., Junge, J.M., Drummond, G.S., Translational significance of heme oxygenase in obesity and metabolic syndrome. Trends Pharmacol. Sci. 3:October (2015), S0165–S6147 pii/00202.
16. [16] Sodhi, K., Inoue, K., Gotlinger, K.H., Canestraro, M., Vanella, L., Kim, D.H., et al. Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice. J. Pharmacol. Exp. Ther. 331/3 (2009), 906–916.
17. [17] Goodman, A.I., Chander, P.N., Rezzani, R., Schwartzman, M.L., Regan, R.F., Rodella, L., et al. Heme oxygenase-2 deficiency contributes to diabetes-mediated increase in superoxide anion and renal dysfunction. J. Am. Soc. Nephrol. 17/4 (2006), 1073–1081.
18. [18] Dennery, P.A., Spitz, D.R., Yang, G., Tatarov, A., Lee, C.S., Shegog, M.L., et al. Oxygen toxicity and iron accumulation in the lungs of mice lacking heme oxygenase-2. J. Clin. Invest. 101/5 (1998), 1001–1011.
19. [19] Li, M., Kim, D.H., Tsenovoy, P.L., Peterson, S.J., Rezzani, R., Rodella, L.F., et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57/6 (2008), 1526–1535.
20. [20] Cao, J., Sodhi, K., Puri, N., Monu, S.R., Rezzani, R., Abraham, N.G., High fat diet enhances cardiac abnormalities in SHR rats: protective role of heme oxygenase-adiponectin axis. Diabetol. Metab. Syndr., 3/1, 2011, 37.
21. [21] Cao, J., Inoue, K., Sodhi, K., Puri, N., Peterson, S.J., Rezzani, R., et al. High-fat diet exacerbates renal dysfunction in SHR: reversal by induction of HO-1-adiponectin axis. Obesity (Silver Spring) 20/5 (2012), 945–953.
22. [22] Vanella, L., Sodhi, K., Kim, D.H., Puri, N., Maheshwari, M., Hinds, T.D. Jr., et al. Increased heme-oxygenase 1 expression decreases adipocyte differentiation and lipid accumulation in mesenchymal stem cells via upregulation of the canonical Wnt signaling cascade. Stem Cell Res. Ther., 4/2, 2013, 28.
23. [23] Vanella, L., Kim, D.H., Asprinio, D., Peterson, S.J., Barbagallo, I., Vanella, A., et al. HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. Bone 46/1 (2010), 236–243.
24. [24] Puigserver, P., Wu, Z., Park, C.W., Graves, R., Wright, M., Spiegelman, B.M., A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92/6 (1998), 829–839.
25. [25] Fernandez-Marcos, P.J., Auwerx, J., Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am. J. Clin. Nutr. 93/4 (2011), 884S–890S.
26. [26] Seale, P., Bjork, B., Yang, W., Kajimura, S., Chin, S., Kuang, S., et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 454/7207 (2008), 961–967.
27. [27] Hondares, E., Rosell, M., Diaz-Delfin, J., Olmos, Y., Monsalve, M., Iglesias, R., et al. Peroxisome proliferator-activated receptor alpha (PPARalpha) induces PPARgamma coactivator 1alpha (PGC-1alpha) gene expression and contributes to thermogenic activation of brown fat: involvement of PRDM16. J. Biol. Chem. 286/50 (2011), 43112–43122.
28. [28] Cohen, P., Spiegelman BM. Brown and Beige fat molecular parts of a thermogenic machine. Diabetes 64/7 (2015), 2346–2351.
29. [29] Wenz, T., Rossi, S.G., Rotundo, R.L., Spiegelman, B.M., Moraes, C.T., Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc. Natl. Acad. Sci. U. S. A. 106/48 (2009), 20405–20410.
30. [30] Garnier, A., Fortin, D., Zoll, J., N'Guessan, B., Mettauer, B., Lampert, E., et al. Coordinated changes in mitochondrial function and biogenesis in healthy and diseased human skeletal muscle. FASEB J. 19/1 (2005), 43–52.
31. [31] Mootha, V.K., Lindgren, C.M., Eriksson, K.F., Subramanian, A., Sihag, S., Lehar, J., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34/3 (2003), 267–273.
32. [32] Patti, M.E., Butte, A.J., Crunkhorn, S., Cusi, K., Berria, R., Kashyap, S., et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: potential role of PGC1 and NRF1. Proc. Natl. Acad. Sci. U. S. A. 100/14 (2003), 8466–8471.
33. [33] Semple, R.K., Crowley, V.C., Sewter, C.P., Laudes, M., Christodoulides, C., Considine, R.V., et al. Expression of the thermogenic nuclear hormone receptor coactivator PGC-1alpha is reduced in the adipose tissue of morbidly obese subjects. Int. J. Obes. Relat. Metab. Disord. 28/1 (2004), 176–179.
34. [34] Hammarstedt, A., Jansson, P.A., Wesslau, C., Yang, X., Smith, U., Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance. Biochem. Biophys. Res. Commun. 301/2 (2003), 578–582.
35. [35] Kleiner, S., Mepani, R.J., Laznik, D., Ye, L., Jurczak, M.J., Jornayvaz, F.R., et al. Development of insulin resistance in mice lacking PGC-1alpha in adipose tissues. Proc. Natl. Acad. Sci. U. S. A. 109/24 (2012), 9635–9640.
36. [36] Bostrom, P., Wu, J., Jedrychowski, M.P., Korde, A., Ye, L., Lo, J.C., et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481/7382 (2012), 463–468.
37. [37] Arany, Z., Wagner, B.K., Ma, Y., Chinsomboon, J., Laznik, D., Spiegelman, B.M., Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 105/12 (2008), 4721–4726.
38. [38] Kong, X., Wang, R., Xue, Y., Liu, X., Zhang, H., Chen, Y., et al. Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One, 5/7, 2010, e11707.
39. [39] Hirschey, M.D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D.B., et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464/7285 (2010), 121–125.
40. [40] Chang, C.R., Blackstone, C., Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. Ann. N. Y. Acad. Sci. 1201 (2010), 34–39.
41. [41] Lionetti, L., Mollica, M.P., Donizzetti, I., Gifuni, G., Sica, R., Pignalosa, A., et al. High-lard and high-fish-oil diets differ in their effects on function and dynamic behaviour of rat hepatic mitochondria. PLoS One, 9/3, 2014, e92753.
42. [42] Alavi, M.V., Fuhrmann, N., Dominant optic atrophy OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics. Mol. Neurodegener., 8, 2013, 32.
43. [43] Chan, D.C., Mitochondria: dynamic organelles in disease, aging, and development. Cell 125/7 (2006), 1241–1252.
44. [44] Bach, D., Pich, S., Soriano, F.X., Vega, N., Baumgartner, B., Oriola, J., et al. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J. Biol. Chem. 278/19 (2003), 17190–17197.
45. [45] Civitarese, A.E., Ravussin, E., Mitochondrial energetics and insulin resistance. Endocrinology 149/3 (2008), 950–954.
46. [46] Waldman, M., Bellner, L., Vanella, L., Schragenheim, J., Sodhi, K., Singh, S.P., et al. Epoxyeicosatrienoic acids regulate adipocyte differentiation of mouse 3T3Cells, via PGC-1alpha activation, which is required for HO-1 expression and increased mitochondrial function. Stem Cells Dev., 2016.
47. [47] Ko, G.T., Chan, J.C., Woo, J., Lau, E., Yeung, V.T., Chow, C.C., Li, J.K., So, W.Y., Cockram, C.S., Serum bilirubin and cardiovascular risk factors in a Chinese population. J. Cardiovasc. Risk 3:October (5) (1996), 459–463 PMID: 9048262.
48. [48] Puigserver, P., Spiegelman, B.M., Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24/1 (2003), 78–90.
49. [49] Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98/1 (1999), 115–124.
50. [50] St-Pierre, J., Lin, J., Krauss, S., Tarr, P.T., Yang, R., Newgard, C.B., et al. Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J. Biol. Chem. 278/29 (2003), 26597–26603.
51. [51] Lin, J., Wu, P.H., Tarr, P.T., Lindenberg, K.S., St-Pierre, J., Zhang, C.Y., et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119/1 (2004), 121–135.
52. [52] Puigserver, P., Adelmant, G., Wu, Z., Fan, M., Xu, J., O'Malley, B., et al. Activation of PPARgamma coactivator-1 through transcription factor docking. Science 286/5443 (1999), 1368–1371.
53. [53] Fandrey, J., Bunn, H.F., In vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reaction. Blood 81/3 (1993), 617–623.
54. [54] Handschin, C., Spiegelman, B.M., Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 27/7 (2006), 728–735.
55. [55] Wang, L., Chen, M., Yuan, L., Xiang, Y., Zheng, R., Zhu, S., 14,15-EET promotes mitochondrial biogenesis and protects cortical neurons against oxygen/glucose deprivation-induced apoptosis. Biochem. Biophys. Res. Commun. 450/1 (2014), 604–609.
56. [56] Canto, C., Auwerx, J., PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr. Opin. Lipidol. 20/2 (2009), 98–105.
57. [57] Nemoto, S., Fergusson, M.M., Finkel, T., SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J. Biol. Chem. 280/16 (2005), 16456–16460.
58. [58] Vanella, L., Kim, D.H., Sodhi, K., Barbagallo, I., Burgess, A.P., Falck, J.R., et al. Crosstalk between EET and HO-1 downregulates Bach1 and adipogenic marker expression in mesenchymal stem cell derived adipocytes. Prostaglandins Other Lipid Mediat. 96/1–4 (2011), 54–62.
59. [59] Chen, J.J., London, I.M., Hemin enhances the differentiation of mouse 3T3 cells to adipocytes. Cell 26/1:Pt 1 (1981), 117–122.
60. [60] Puri, N., Sodhi, K., Haarstad, M., Kim, D.H., Bohinc, S., Foglio, E., et al. Heme induced oxidative stress attenuates sirtuin1 and enhances adipogenesis in mesenchymal stem cells and mouse pre-adipocytes. J. Cell. Biochem. 113/6 (2012), 1926–1935.
61. [61] Wu, N., Yin, L., Hanniman, E.A., Joshi, S., Lazar, M.A., Negative feedback maintenance of heme homeostasis by its receptor, Rev-erbalpha. Genes Dev. 23/18 (2009), 2201–2209.
62. [62] Handschin, C., Lin, J., Rhee, J., Peyer, A.K., Chin, S., Wu, P.H., et al. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1alpha. Cell 122/4 (2005), 505–515.
63. [63] Abraham, N.G., Kappas, A., Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 60/1 (2008), 79–127.
64. [64] Turkseven, S., Drummond, G., Rezzani, R., Rodella, L., Quan, S., Ikehara, S., et al. Impact of silencing HO-2 on EC-SOD and the mitochondrial signaling pathway. J. Cell. Biochem. 100/4 (2007), 815–823.
65. [65] Olszanecki, R., Rezzani, R., Omura, S., Stec, D.E., Rodella, L., Botros, F.T., et al. Genetic suppression of HO-1 exacerbates renal damage: reversed by an increase in the antiapoptotic signaling pathway. Am. J. Physiol. Renal Physiol. 292/1 (2007), F148–F157.
66. [66] Di Noia, M.A., Van, D.S., Palmieri, F., Yang, L.M., Quan, S., Goodman, A.I., et al. Heme oxygenase-1 enhances renal mitochondrial transport carriers and cytochrome C oxidase activity in experimental diabetes. J. Biol. Chem. 281/23 (2006), 15687–15693.
67. [67] Piantadosi, C.A., Carraway, M.S., Babiker, A., Suliman, H.B., Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1. Circ. Res. 103/11 (2008), 1232–1240.
68. [68] Hull, T.D., Boddu, R., Guo, L., Tisher, C.C., Traylor, A.M., Patel, B., et al. Heme oxygenase-1 regulates mitochondrial quality control in the heart. JCI Insight, 1/2, 2016, e85817.
69. [69] Issan, Y., Kornowski, R., Aravot, D., Shainberg, A., Laniado-Schwartzman, M., Sodhi, K., et al. Heme oxygenase-1 induction improves cardiac function following myocardial ischemia by reducing oxidative stress. PLoS One, 9/3, 2014, e92246.
70. [70] Abraham, N.G., Lutton, J.D., Freedman, M.L., Levere, R.D., Benzene modulation of liver cell structure and heme-cytochrome P-450 metabolism. Am. J. Med. Sci. 292/2 (1986), 81–86.
71. [71] Burgess, A.P., Vanella, L., Bellner, L., Gotlinger, K., Falck, J.R., Abraham, N.G., et al. Heme oxygenase (HO-1) rescue of adipocyte dysfunction in HO-2 deficient mice via recruitment of epoxyeicosatrienoic acids (EETs) and adiponectin. Cell. Physiol. Biochem. 29/1–2 (2012), 99–110.
72. [72] Kawakami, T., Puri, N., Sodhi, K., Bellner, L., Takahashi, T., Morita, K., et al. Reciprocal effects of oxidative stress on heme oxygenase expression and activity contributes to reno-vascular abnormalities in EC-SOD knockout mice. Int. J. Hypertens., 2012, 2012, 740203.
73. [73] Li, Y., Park, J.S., Deng, J.H., Bai, Y., Cytochrome c oxidase subunit IV is essential for assembly and respiratory function of the enzyme complex. J. Bioenerg. Biomembr. 38/5–6 (2006), 283–291.
74. [74] Barrientos, A., Barros, M.H., Valnot, I., Rotig, A., Rustin, P., Tzagoloff, A., Cytochrome oxidase in health and disease. Gene 286/1 (2002), 53–63.
75. [75] Diaz, F., Cytochrome c oxidase deficiency: patients and animal models. Biochim. Biophys. Acta 1802/1 (2010), 100–110.
76. [76] Huttemann, M., Lee, I., Gao, X., Pecina, P., Pecinova, A., Liu, J., et al. Cytochrome c oxidase subunit 4 isoform 2-knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology. FASEB J. 26/9 (2012), 3916–3930.
77. [77] Wang, L., Chen, M., Yuan, L., Xiang, Y., Zheng, R., Zhu, S., 14,15-EET promotes mitochondrial biogenesis and protects cortical neurons against oxygen/glucose deprivation-induced apoptosis. Biochem. Biophys. Res. Commun. 450/1 (2014), 604–609.
78. [78] Murphy, E., Ardehali, H., Balaban, R.S., DiLisa, F., Dorn, G.W., Kitsis, R.N., et al. Mitochondrial function, biology, and role in disease: a scientific statement from the american heart association. Circ. Res., 2016.
79. [79] S. Zuchner, J.M. Vance, Charcot-Marie-Tooth Neuropathy Type 4A. 1993.
80. [80] Sebastian, D., Hernandez-Alvarez, M.I., Segales, J., Sorianello, E., Munoz, J.P., Sala, D., et al. Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc. Natl. Acad. Sci. U. S. A. 109/14 (2012), 5523–5528.